Biophan Technologies, Inc., Formerly GreatBio Technologies, Inc., Announces Change of Name and Trading Symbol.Business/Technology & Health Editors ROCHESTER, N.Y.--(BUSINESS WIRE)--Aug. 21, 2001 Biophan Technologies, Inc. ("Biophan" or the "Company")(OTC OTC See: Over-the-counter. OTC See over-the-counter market (OTC). BB: BIPH BIPH Bogomoletz Institute of Physiology (National Academy of Sciences; Ukraine) ) of West Henrietta, New York Henrietta is a town in Monroe County, New York, United States. It is a suburb of Rochester. The population was 39,028 at the 2000 census. The town is named after Henrietta Laura Pulteney, Countess of Bath, daughter of Sir William Pulteney, 5th Baronet, a major British investor in announced today that the Company has changed its name and trading symbol from GreatBio Technologies, Inc. (GBTI) to Biophan Technologies, Inc. (BIPH). The change, effective on July 19, 2001, and approved by the Company's shareholders, was made to avoid potential confusion with other public companies having similar names. Biophan is currently focusing on two technologies. The first is new proprietary technology that will enable implantable cardiac pacemakers and other life-sustaining medical devices to operate in the presence of magnetic resonance imaging magnetic resonance imaging (MRI), noninvasive diagnostic technique that uses nuclear magnetic resonance to produce cross-sectional images of organs and other internal body structures. (MRI 1. (application) MRI - Magnetic Resonance Imaging. 2. MRI - Measurement Requirements and Interface. ) equipment. The underlying technology, which was acquired by the Company, is based on patent applications and proprietary knowledge developed by Wilson Greatbatch, the inventor of the original implantable cardiac pacemaker. The second technology is proprietary antisense antisense, DNA or RNA manipulated in a laboratory so that its components (nucleotides) form a complementary copy of normal, or "sense," messenger RNA (mRNA; see nucleic acid). gene therapy technology to inhibit the spread of human immunodeficiency virus human immunodeficiency virus n. HIV. Human immunodeficiency virus (HIV) A transmissible retrovirus that causes AIDS in humans. (HIV-1) infection in conjunction with the use of lentiviral vectors. This technology is based on patents issued to Mr. Greatbatch and acquired by the Company. Safe Harbor Statement: Certain statements included in this press release are forward-looking statements within the meaning of the Private Securities Litigation Reform Act The Private Securities Litigation Reform Act of 1995 (PSLRA) implemented several significant substantive changes affecting certain cases brought under the federal securities laws, including changes related to pleading, discovery, liability, class representation and awards fees and of 1995. Actual results could differ materially from such statements expressed or implied herein as a result of a variety of factors including, but not limited to: the development of the Company's MRI and gene therapy technologies; the approval of the Company's patent applications; the successful implementation of the Company's research and development programs; the acceptance by the market of the Company's products; competition and the timing of projects and trends in future operating performance, as well as other factors expressed from time to time in the Company's periodic filings with the Securities and Exchange Commission (the "SEC"). As a result, this press release should be read in conjunction with the Company's periodic filings with the SEC. The forward-looking statements contained herein are made only as of the date of this press release, and the Company undertakes no obligation to publicly update such forward-looking statements to reflect subsequent events or circumstances. |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion